Evogene Dirección
Dirección controles de criterios 4/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Ofer Haviv
Chief Executive Officer (CEO)
US$401.0k
Compensación total
| Porcentaje del salario del CEO | 97.3% |
| Permanencia del CEO | 19.9yrs |
| Participación del CEO | n/a |
| Permanencia media de la dirección | 2.6yrs |
| Promedio de permanencia en la Junta Directiva | 5.8yrs |
Actualizaciones recientes de la dirección
Recent updates
Evogene unit files for EPA approval of bio-fungicide LAV.311 for fruit rots
Oct 12Evogene unit launches 2nd-gen medical cannabis products in Israel
Sep 21Lavie Bio appoints Guri Oron as CEO
Sep 14Evogene GAAP EPS of -$0.42 misses by $0.23, revenue of $0.55M beats by $0.33M
Aug 31Evogene regains compliance with Nasdaq's minimum bid price requirement
Aug 25Evogen stock rises after unit gets $10M investment from ICL under collaboration agreement
Aug 17Update On Evogene's Subsidiaries: Biomica, Lavie Bio And AgPlenus
Mar 22Evogene: Computational Biology Technology Hub; Focus On Canonic (Medical Cannabis)
Mar 03Evogene's Canonic Begins Selling High THC Cannabis In Israeli Medical Market
Sep 14Evogene: Bullish With Canonic's Entry Into Israeli Medical Cannabis Markets
Jun 16Evogene EPS beats by $0.01, beats on revenue
May 26Evogene unit - Canonic inks cultivation deal for medical cannabis varieties
Dec 23AgPlenus reaches a 'Lead' Stage in its mode-of-action herbicide program
Dec 15Evogene: Q3 Update And Upcoming Catalysts
Nov 30Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$20m |
| Mar 31 2024 | n/a | n/a | -US$21m |
| Dec 31 2023 | US$401k | US$390k | -US$24m |
| Sep 30 2023 | n/a | n/a | -US$20m |
| Jun 30 2023 | n/a | n/a | -US$23m |
| Mar 31 2023 | n/a | n/a | -US$25m |
| Dec 31 2022 | US$464k | US$415k | -US$27m |
| Sep 30 2022 | n/a | n/a | -US$31m |
| Jun 30 2022 | n/a | n/a | -US$32m |
| Mar 31 2022 | n/a | n/a | -US$29m |
| Dec 31 2021 | US$530k | US$420k | -US$28m |
| Sep 30 2021 | n/a | n/a | -US$29m |
| Jun 30 2021 | n/a | n/a | -US$26m |
| Mar 31 2021 | n/a | n/a | -US$24m |
| Dec 31 2020 | US$592k | US$367k | -US$23m |
| Sep 30 2020 | n/a | n/a | -US$21m |
| Jun 30 2020 | n/a | n/a | -US$21m |
| Mar 31 2020 | n/a | n/a | -US$21m |
| Dec 31 2019 | US$538k | US$366k | -US$18m |
| Sep 30 2019 | n/a | n/a | -US$18m |
| Jun 30 2019 | n/a | n/a | -US$18m |
| Mar 31 2019 | n/a | n/a | -US$19m |
| Dec 31 2018 | US$517k | US$324k | -US$21m |
| Sep 30 2018 | n/a | n/a | -US$21m |
| Jun 30 2018 | n/a | n/a | -US$21m |
| Mar 31 2018 | n/a | n/a | -US$21m |
| Dec 31 2017 | US$649k | US$359k | -US$21m |
Compensación vs. Mercado: La compensación total de Ofer($USD401.00K) está por debajo de la media de empresas de tamaño similar en el mercado US ($USD645.01K).
Compensación vs. Ingresos: La compensación de Ofer ha sido consistente con los resultados de la empresa en el último año.
CEO
Ofer Haviv (58 yo)
19.9yrs
Permanencia
US$401,000
Compensación
Mr. Ofer Haviv, CPA, served as Interim Chief Executive Officer of Lavie Bio Ltd. since January 2023. He has been Chief Executive Officer and President of Evogene Limited since December 2004 and served as i...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & President | 19.9yrs | US$401.00k | sin datos | |
| Chief Executive Officer of AgPlenus Ltd | 2.9yrs | US$456.00k | sin datos | |
| Chief Executive Officer of Biomica Ltd | 6.8yrs | US$339.00k | 0% $ 0 | |
| Chief Executive Officer of Lavie Bio Ltd. | 1.6yrs | US$606.00k | sin datos | |
| Chief Financial Officer | 2.6yrs | sin datos | 0% $ 0 | |
| Head of Investor Relations | 1.4yrs | sin datos | sin datos | |
| Vice President of Corporate Development | 2.8yrs | US$304.00k | 0% $ 0 | |
| Vice President of Human Resources | 2.8yrs | sin datos | sin datos | |
| Executive Vice President of Business Development | 2.4yrs | sin datos | 0% $ 0 | |
| Chief Executive Officer of Casterra Ag Ltd. | less than a year | sin datos | sin datos | |
| Chief Executive Officer of Ag Plenus Ltd. | less than a year | sin datos | sin datos | |
| Vice President of Commercial of Lavie Bio Ltd. | no data | sin datos | sin datos |
2.6yrs
Permanencia media
53yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de EVGN se considera experimentado (2.6 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Independent Director | 3yrs | sin datos | 0% $ 0 | |
| Independent Director | 2yrs | sin datos | 0% $ 0 | |
| Independent Director | 19.5yrs | sin datos | 1.56% $ 162.9k | |
| Independent Chairperson of the Board | 8.3yrs | sin datos | 0% $ 0 | |
| Independent Director | 6yrs | sin datos | 0% $ 0 | |
| Independent Director | 5.8yrs | sin datos | 0% $ 0 | |
| Scientific Advisor | 2.8yrs | sin datos | sin datos |
5.8yrs
Permanencia media
63.5yo
Promedio de edad
Junta con experiencia: La junta directiva de EVGN se considera experimentada (5.8 años de antigüedad promedio).